Literature DB >> 12663585

Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients.

Paolo Fiorina1, Franco Folli, Federico Bertuzzi, Paola Maffi, Giovanna Finzi, Massimo Venturini, Carlo Socci, Alberto Davalli, Elena Orsenigo, Lucilla Monti, Luca Falqui, Silvia Uccella, Stefano La Rosa, Luciana Usellini, Giuliana Properzi, Valerio Di Carlo, Alessandro Del Maschio, Carlo Capella, Antonio Secchi.   

Abstract

OBJECTIVE: Our aim was to evaluate the long-term effects of transplanted islets on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. RESEARCH DESIGN AND METHODS: A total of 34 type 1 diabetic kidney-transplanted patients underwent islet transplantation and were divided into two groups: successful islet-kidney transplantation (SI-K; 21 patients, fasting C-peptide serum concentration >0.5 ng/ml for >1 year) and unsuccessful islet-kidney transplantation (UI-K; 13 patients, fasting C-peptide serum concentration <0.5 ng/ml). Patients cumulative survival, cardiovascular death rate, and atherosclerosis progression were compared in the two groups. Skin biopsies, endothelial dependent dilation (EDD), nitric oxide (NO) levels, and atherothrombotic risk factors [von Willebrand factor (vWF) and D-dimer fragment (DDF)] were studied cross-sectionally.
RESULTS: The SI-K group showed a significant better patient survival rate (SI-K 100, 100, and 90% vs. UI-K 84, 74, and 51% at 1, 4, and 7 years, respectively, P = 0.04), lower cardiovascular death rate (SI-K 1/21 vs. UI-K 4/13, chi(2) = 3.9, P = 0.04), and lower intima-media thickness progression than the UI-K group (SI-K group: delta1-3 years -13 +/- 30 micro m vs. UI-K group: delta1-3 years 245 +/- 20 micro m, P = 0.03) with decreased signs of endothelial injuring at skin biopsy. Furthermore, the SI-K group showed a higher EDD than the UI-K group (EDD: SI-K 7.8 +/- 4.5% vs. UI-K 0.5 +/- 2.7%, P = 0.02), higher basal NO (SI-K 42.9 +/- 6.5 vs. UI-K 20.2 +/- 6.8 micro mol/l, P = 0.02), and lower levels of vWF (SI-K 138.6 +/- 15.3 vs. UI-K 180.6 +/- 7.0%, P = 0.02) and DDF (SI-K 0.61 +/- 0.22 vs. UI-K 3.07 +/- 0.68 micro g/ml, P < 0.01). C-peptide-to-creatinine ratio correlated positively with EDD and NO and negatively with vWF and DDF.
CONCLUSIONS: Successful islet transplantation improves survival, cardiovascular, and endothelial function in type 1 diabetic kidney-transplanted patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663585     DOI: 10.2337/diacare.26.4.1129

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  30 in total

Review 1.  Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes.

Authors:  Carmen Fotino; Camillo Ricordi; Vincenzo Lauriola; Rodolfo Alejandro; Antonello Pileggi
Journal:  Rev Diabet Stud       Date:  2010-08-10

Review 2.  Islet Transplantation Alone Versus Solitary Pancreas Transplantation: an Outcome-Driven Choice?

Authors:  Paola Maffi; Antonio Secchi
Journal:  Curr Diab Rep       Date:  2019-04-25       Impact factor: 4.810

Review 3.  Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers.

Authors:  Fanny Buron; Sophie Reffet; Lionel Badet; Emmanuel Morelon; Olivier Thaunat
Journal:  Curr Diab Rep       Date:  2021-04-25       Impact factor: 4.810

Review 4.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 5.  Advances in β-cell replacement therapy for the treatment of type 1 diabetes.

Authors:  Marie-Christine Vantyghem; Eelco J P de Koning; François Pattou; Michael R Rickels
Journal:  Lancet       Date:  2019-09-15       Impact factor: 79.321

6.  Single-centre experience of extending indications for percutaneous intraportal islet autotransplantation (PIPIAT) after pancreatic surgery to prevent diabetes: feasibility, radiological aspects, complications and clinical outcome.

Authors:  Massimo Venturini; Claudio Sallemi; Caterina Colantoni; Giulia Agostini; Gianpaolo Balzano; Antonio Esposito; Antonio Secchi; Francesco De Cobelli; Massimo Falconi; Lorenzo Piemonti; Paola Maffi; Alessandro Del Maschio
Journal:  Br J Radiol       Date:  2016-06-21       Impact factor: 3.039

Review 7.  Pancreas transplantation: solid organ and islet.

Authors:  Shruti Mittal; Paul Johnson; Peter Friend
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

Review 8.  Point: steady progress and current challenges in clinical islet transplantation.

Authors:  Davide Mineo; Antonello Pileggi; Rodolfo Alejandro; Camillo Ricordi
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

9.  Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation.

Authors:  Franco Folli; Valeria Guzzi; Lucia Perego; Dawn K Coletta; Giovanna Finzi; Claudia Placidi; Stefano La Rosa; Carlo Capella; Carlo Socci; Davide Lauro; Devjit Tripathy; Christopher Jenkinson; Rita Paroni; Elena Orsenigo; Giuliana Cighetti; Luisa Gregorini; Carlo Staudacher; Antonio Secchi; Angela Bachi; Michael Brownlee; Paolo Fiorina
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

Review 10.  Islet transplantation a decade later and strategies for filling a half-full glass.

Authors:  R Paul Robertson
Journal:  Diabetes       Date:  2010-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.